Literature DB >> 27986817

The slow growing embryo and premature progesterone elevation: compounding factors for embryo-endometrial asynchrony.

Mae Wu Healy1,2, Meghan Yamasaki2, George Patounakis3, Kevin S Richter4, Kate Devine4, Alan H DeCherney3, Micah J Hill3,2.   

Abstract

STUDY QUESTION: Is there an association of progesterone (P4) on the day of trigger with live birth in autologous ART transfer cycles on day 5 versus day 6? SUMMARY ANSWER: P4 had a greater negative effect on live birth in day 6 fresh transfers compared to day 5 fresh transfers. WHAT IS KNOWN ALREADY: Premature P4 elevation is associated with lower live birth rates in fresh autologous ART cycles, likely due to worsened endometrial-embryo asynchrony. Few studies have evaluated whether the effect of an elevated P4 on the day of trigger is different on live birth rates with a day 5 compared to a day 6 embryo transfer. STUDY DESIGN SIZE, DURATION: This was a retrospective cohort study with autologous IVF cycles with fresh embryo transfers on day 5 and day 6 from 2011 to 2014. A total of 4120 day 5 and 230 day 6 fresh autologous embryo transfers were included. The primary outcome was live birth, defined as a live born baby at 24 weeks gestation or later. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Patients from a large private ART practice were included. Analysis was performed with generalized estimating equations (GEE) modeling and receiver operating characteristic (ROC) curves. MAIN RESULTS AND THE ROLE OF CHANCE: Day 6 transfers were less likely to have good quality embryos (73% versus 83%, P < 0.001) but the cohorts had similar rates of blastocyst stage transfer (92% versus 91%, P = 0.92). Live birth was less likely in fresh day 6 versus day 5 embryo transfers (34% versus 46%, P = 0.01) even when controlling for embryo confounders. In adjusted GEE models, the effect of P4 as a continuous variable on live birth was more pronounced on day 6 (P < 0.001). Similarly, the effect of P4 > 1.5 ng/ml on day of trigger was more pronounced on day 6 than day 5 (P < 0.001). Day 6 live birth rates were 8% lower than day 5 when P4 was in the normal range (P = 0.04), but became 17% lower when P4 was > 1.5 ng/ml (P < 0.01). ROC curves for P4 predicting live birth demonstrated a greater AUC in day 6 transfers (AUC 0.59, 95% CI 0.51-0.66) than day 5 (AUC 0.54, 95% CI 0.52-0.55). Interaction testing of P4 × day of embryo transfer was highly significant (P < 0.001), further suggesting that the effect of P4 was more pronounced on day 6 embryo transfer. In fresh oocyte retrieval cycles with elevated P4, a subsequent 760 frozen-thaw transfers did not demonstrate a difference between embryos that were frozen after blastulation on day 5 versus 6. LIMITATIONS REASONS FOR CAUTION: Limitations include the retrospective design and the inability to control for certain confounding variables, such as thaw survival rates between day 5 and day 6 blastocysts. Also, the data set lacks the known ploidy status of the embryos and the progesterone assay is not currently optimized to discriminate between patients with a P4 of 1.5 versus 1.8 ng/ml. WIDER IMPLICATIONS OF THE
FINDINGS: This study suggests further endometrial-embryo asynchrony when a slow growing embryo is combined with an advanced endometrium, ultimately leading to decreased live births. This suggests that premature elevated P4 may be a factor in the lower live birth rates in day 6 fresh embryo transfers. Further studies are needed to evaluate if a frozen embryo transfer cycle can ameliorate the effect of elevated P4 on the day of trigger among these slower growing embryos that reach blastocyst staging on day 6. STUDY FUNDING/COMPETING INTERESTS: No external funding was received for this study. There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: Not applicable. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  day 5 versus day 6 embryo transfer cycles; elevated progesterone; fresh transfer versus frozen embryo transfer cycles; live birth

Mesh:

Substances:

Year:  2016        PMID: 27986817      PMCID: PMC6260420          DOI: 10.1093/humrep/dew296

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

1.  Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression.

Authors:  I Van Vaerenbergh; H M Fatemi; C Blockeel; L Van Lommel; P In't Veld; F Schuit; E M Kolibianakis; P Devroey; C Bourgain
Journal:  Reprod Biomed Online       Date:  2010-11-13       Impact factor: 3.828

Review 2.  Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent normal birth in spite of a capable embryo.

Authors:  Jason M Franasiak; Maria Ruiz-Alonso; Richard T Scott; Carlos Simón
Journal:  Fertil Steril       Date:  2016-04       Impact factor: 7.329

3.  Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?

Authors:  Matthew T Connell; George Patounakis; Mae Wu Healy; Alan H DeCherney; Kate Devine; Eric Widra; Michael J Levy; Micah J Hill
Journal:  Fertil Steril       Date:  2016-05-10       Impact factor: 7.329

4.  The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: a prospective randomized clinical study.

Authors:  Shuo Yang; Tianshu Pang; Rong Li; Rui Yang; Xiumei Zhen; Xinna Chen; Haiyan Wang; Caihong Ma; Ping Liu; Jie Qiao
Journal:  Gynecol Endocrinol       Date:  2015-01-05       Impact factor: 2.260

5.  Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?

Authors:  Micah J Hill; Greene Donald Royster; Mae Wu Healy; Kevin S Richter; Gary Levy; Alan H DeCherney; Eric D Levens; Geeta Suthar; Eric Widra; Michael J Levy
Journal:  Fertil Steril       Date:  2015-04-14       Impact factor: 7.329

6.  Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis.

Authors:  E Labarta; J A Martínez-Conejero; P Alamá; J A Horcajadas; A Pellicer; C Simón; E Bosch
Journal:  Hum Reprod       Date:  2011-05-02       Impact factor: 6.918

7.  Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.

Authors:  Bei Xu; Zhou Li; Hanwang Zhang; Lei Jin; Yufeng Li; Jihui Ai; Guijin Zhu
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

8.  Embryo cryopreservation rescues cycles with premature luteinization.

Authors:  Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson; Shyni Thomas
Journal:  Fertil Steril       Date:  2009-03-17       Impact factor: 7.329

9.  Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?

Authors:  Mae Wu Healy; George Patounakis; Matt T Connell; Kate Devine; Alan H DeCherney; Michael J Levy; Micah J Hill
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

10.  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.

Authors:  Georg Griesinger; Bernadette Mannaerts; Claus Yding Andersen; Han Witjes; Efstratios M Kolibianakis; Keith Gordon
Journal:  Fertil Steril       Date:  2013-09-29       Impact factor: 7.329

View more
  8 in total

Review 1.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

2.  Day 5 versus Day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes.

Authors:  Mathilde Bourdon; Khaled Pocate-Cheriet; Astri Finet de Bantel; Veronika Grzegorczyk-Martin; Aureli Amar Hoffet; Elisangela Arbo; Marine Poulain; Pietro Santulli
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.918

Review 3.  The curious case of premature luteinization.

Authors:  Apostolos Kaponis; Elpiniki Chronopoulou; George Decavalas
Journal:  J Assist Reprod Genet       Date:  2018-07-26       Impact factor: 3.412

Review 4.  Towards an Improved Understanding of the Effects of Elevated Progesterone Levels on Human Endometrial Receptivity and Oocyte/Embryo Quality during Assisted Reproductive Technologies.

Authors:  Nischelle R Kalakota; Lea C George; Sara S Morelli; Nataki C Douglas; Andy V Babwah
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

5.  Progesterone levels on the human chorionic gonadotropin trigger day affect the pregnancy rates for embryos transferred at different stages of development in both general and selected IVF/ICSI populations.

Authors:  P Merviel; S Bouée; A S Jacamon; J J Chabaud; M T Le Martelot; S Roche; C Rince; H Drapier; A Perrin; D Beauvillard
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-06       Impact factor: 3.007

6.  Effect of the time for embryo transfer from oocyte retrieval on clinical outcomes in freeze-all cycles: a retrospective cohort study.

Authors:  Shiping Chen; Yachao Yao; Yang Luo; Yuling Mao; Hanyan Liu; Hongzi Du; Xiangjin Kang; Lei Li
Journal:  Arch Gynecol Obstet       Date:  2020-01-04       Impact factor: 2.493

7.  Elevated serum progesterone does not impact euploidy rates in PGT-A patients.

Authors:  Maria Luisa Pardiñas; Mar Nohales; Elena Labarta; José María De Los Santos; Amparo Mercader; José Remohí; Ernesto Bosch; Maria José De Los Santos
Journal:  J Assist Reprod Genet       Date:  2021-05-18       Impact factor: 3.357

8.  EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays.

Authors:  N P Polyzos; E Anckaert; P Drakopoulos; H Tournaye; J Schiettecatte; H Donner; G Bobba; G Miles; W D J Verhagen-Kamerbeek; E Bosch
Journal:  J Endocrinol Invest       Date:  2020-03-13       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.